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INTRODUCTION
Tuberculosis (TB) is an important public health 
problem worldwide. Indonesia is a country with the 
third highest prevalence of TB in the world, right 
after China and India. Based on the 1985 Household 
Health Survey and the 2001 National Health Survey, 
TB is positioned as the third highest cause of death in 
Indonesia.1,2,3
TB in digestive system is one of the manifestation 
of extrapulmonary TB and comprises of 3-16% of 
all extrapulmonary TB cases. The digestive system 
is involved in 66-75% of patients with abdominal 
TB. The gastrointestinal region that most commonly 
affected is the ileocaecal region.3,4 TB in digestive 
system also has unclear or hidden clinical features with 
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ABSTRACT
Tuberculosis (TB) is a significant public health problem worldwide. Indonesia is a country with the third 
highest prevalence of TB in the world after China and India. TB infection can attack all organs of the human 
body. TB in digestive system is one of the extrapulmonary TB manifestations and comprises of 3-16% of all 
extrapulmonary TB cases. This type of TB may affect digestive system, peritoneum, mesentery lymphatic glands, 
liver, and spleen. Digestive system is affected in 66-75% of patients with abdominal TB. The ileocaecal region 
is most commonly affected. The manifestation of abdominal TB is not specific. Precise diagnostic approach and 
supporting results are needed to determine final diagnosis. However, there is no single examination adequate 
enough to diagnose abdominal TB. If the diagnosis can be established early, this disease could then be managed 
with conventional anti-TB drugs. Treatment for both 6-9 months period and 18-24 months period has been proven 
effective in management of extrapulmonary TB.
In countries with high abdominal TB prevalence, initiation of anti-TB therapy is allowed if there are the 
clinical features present. Diagnosis can be determined when the patient has therapeutic response against the 
the anti-TB treatment.
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no specific laboratory results or radiologic features. 
Clinical evaluation is required for early diagnosis 
and correct treatment.4,5,6 Treatment with the standard 
regimen of drugs for TB in the digestive system is quite 
effective. Steroid as an additional treatment remains 
arguable.1,6,7,8
MORPHOLOGY AND STRUCTURE OF THE BACTERIA 
TB is a disease caused by the infection of 
Mycobacterium tuberculosis (M. tuberculosis) 
complex.3 M. tuberculosis has the shape of straight 
or slightly curved rod, no spores, no capsule, and is 
0.3–0.6 μm in width and 1–4 μm in length. Bacterial 
wall is very complex, comprising of relatively high 
fat layers (60%) which main components are mycolic 
acids, complex waxes, dimycolic trephalose called cord 
factor and mycobacterial sulpholipids which plays a 
role in virulence. Other components of the bacterial 
cell wall are polysaccharides, such as arabinogalactan 
and arabinomannan. The complex structure of the cell 
wall allows the bacteria to be acid-fast in nature.1,2,3
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TRANSMISSION
The process of M. tuberculosis infection is commonly 
transmitted by inhalation leading to pulmonary TB, 
which is the most common clinical manifestation 
compared to other organs. The transmission of this 
disease is mostly achieved by inhaling bacilli which 
contains droplet nuclei specifically from pulmonary 
TB patients with productive cough or hemaptoe which 
contains acid fast bacilli (AFB). Infections caused by 
Mycobacterium bovis might be transmitted through 
milk which is not adequately sterilized or has been 
contaminated.1,2 
Secondary Tuberculosis (Post Primary Tuberculosis)
Dormant microorganisms in primary TB will emerge 
years later as endogenous infection in adults, usually 
occurring in the age of 15-40 years. The majority of 
reinfection is mounting up to 90%. Post primary TB 
starts with a complex commonly located in posterior-
apical segment of either superior or inferior lobes. 
Its invasion is directed to the parenchyma of lungs. This 
early complex is at first shaped as a small pneumonia 
complex. Within 3-10 weeks, it will then become 
a tubercle, a granuloma which consists of histiocytes 
and Datia Langhans cells (giant cells with multiple 
nuclei) which are surrounded with lymphocytes 
and various connective tissues. Depending on 
the number of agents, virulence, and patient’s 
immunity, this pneumonic complex will then follow 
a certain pathway: gets reabsorbed back and heals 
without leaving any marks, spreads and healing process 
begins quickly along with the forming of fibrotic tissue, 
or pneumonic complex spreads widely to form caseous 
tissue. Cavity will emerge as the caseous tissue gets 
coughed out. The cavity will then spread and create 
new pneumonic affect. This pneumonic complex shall 
follow one pattern of pathways as mentioned above, 
get condensed and encapsulates itself and known as 
tuberculoma. It is clear and heals to produce what is 
called open healed cavity, or heals by encapsulating 
itself and finally shrink down.1,2,3
DEFINITION OF COLITIS TUBERCULOSIS
Colitis is an acute or chronic inflamation in colon 
which, based on the etiology, can be classified as 
follows:3,4,5 (1) Infective colitis, such as: shigellosis, 
colitis TB, amebic colitis, pseudomembrane colitis, 
colitis of other viral/bacterial/parasite etiologies; 
(2) Non-infective colitis, such as: ulcerative colitis, 
Crohn’s disease, radiative colitis, non-specific colitis.
Figure 1. Dissemination of tuberculosis2
PATHOGENESIS  OF TUBERCULOSIS
Primary Tuberculosis
TB bacteria which enter respiratory tract will nest 
in lung tissue to form a pneumonic nest called primary 
nest or primary complex or Ghon’s focus. The primary 
complex may emerge in any parts of the lungs, unlike 
the reactivation focus. From the primary complex, 
lymphatic vessels’ inflammation towards the hilus 
(local lymphangitis) shall occur. The inflammation 
is followed by the enlargement of hillar lymph nodes 
(regional lymphadenitis). Primary complex, together 
with local lymphangitis and regional lymphadenitis, is 
known as the primary complex of Ranke.1,2,3
Figure 2. Outcomes of primary infection9
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TB in the digestive system is one of the 
manifestations of extrapulmonary TB and comprises 
of 3-16% of all extrapulmonary TB cases. This type 
of TB can affect the digestive system, peritoneum, 
mesenteric lymph nodes, liver, as well as spleen. 
The digestive system is affected in 66-75% of patients 
with abdominal TB. Guts and peritoneum can be 
infected through mesenteric lymph nodes, infected 
tuba falopii, direct spread from an infected organ, and 
hematogenous spread. Direct infection from the wall of 
the guts is highly possible after drinking unpasteurized 
milk or swallowing a large number of bacilli from the 
pulmonary cavity. Reactivation from the body within 
few years of time after hematogenous spread is highly 
possible.7,8 
have enteric involvement. This big interval is caused 
by the severity of pulmonary TB, where the degree 
of severity of pulmonary TB is directly proportional 
to the incidence of concurrent enteric involvement.7,8 
Table 1. Post primary tuberculosis9
Pulmonary tuberculosis
Extrapulmonary tuberculosis
Common Less common
Cavities Pleural effusion Empyema
Upper lobe infiltrates Lymphadenophaty (usually cervical) Male genital tract (epididymitis, orchitis)
Fibrosis Central nervous system (meningitis, 
cerebral tuberculoma)
Female genital tract (tubo-ovarian, endometrium)
Progressive pneumonia Pericaditis (effusion/constrictive) Kidney
Endobronchial Gastrointestinal (ileocaecal, peritoneal) Adrenal gland
Spine, other bone and joint Skin (lupus vulgaris, tuberculids, miliary)
Figure 3. Distribution of tuberculosis cases by anatomical site in 
HIV negative patients10
Figure 4. Distribution of tuberculosis cases by anatomical site in 
HIV positive patients10
In colitis TB, caecum and ascending colon are two 
areas most frequently affected, followed by transverse 
colon and descending colon. Based on several 
references, 6-90% of patients with pulmonary TB 
Table 2. Anatomic distribution of tuberculosis of the 
intestine (from clinical and necropy series)8
Site Cases (%)
Duodenum 2-3
Jejunum 7-25
Ileum 70-80
Ileocecal area 55-85
Appendix 5-25
Colon 25-50
Rectum 5-10
Anal canal 0-4
On the other side, 7-75% of patients with enteritis 
TB have no history of concurrent pulmonary TB based 
on various reports in Canada, USA, and England. 
Studies in India reported that 60-75% of patients with 
enteritis TB have no association with active pulmonary 
TB, 0-20% have association with active pulmonary TB, 
and 5-40% have association with inactive pulmonary 
TB.7,8,11
PATHOGENESIS OF COLITIS TUBERCULOSIS
The pathogenesis of abdominal TB can be divided 
into 4 mechanisms are swallowing infected sputum, 
hematogenous spread from an active pulmonary 
process or miliary TB, consuming contaminated milk 
or food and direct spread from the adjacent organs. 
Infection may occur primarily in the gastrointestinal 
tract or secondary from other focuses in the body.7,8,11
In the case of ingested tubercle bacilli, intestinal 
TB might be caused by consuming contaminated 
food and milk. Secondary infection can happen 
due to swallowing infectious sputum in patients 
with pulmonary or laryngeal TB. After ingestion, 
bacteria shall pass the stomach and head to the small 
intestine. The lipid capsule protects bacteria from 
digestion process such as the stomach acid secretions. 
In the intestines, germination process takes place in 
PTB : pulmonary   
              tuberculosis
EPTB : extrapulmonary 
              tuberculosis
LNTB   : lymph node 
              tuberculosis
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areas containing many lymphoid tissues, excessively 
static in physiology, areas with high rate of water and 
electrolyte absorption, as well as areas with minimal 
digestive activity.1,7,8,11
While the hematogenous spread from extraintestinal 
focuses of infection involves spreading through blood 
which can occur in primary phase of pulmonary TB 
and in miliary TB. In these conditions, early lesions 
are found in submucosa area, with normal mucosa 
appearance.8,11 
The most frequently affected location is the 
ileocaecal region. The affinity of TB bacilli in this 
region might be due to the presence of many lymphoid 
tissues with relatively slower stream. Microorganisms 
penetrate the mucosa to settle in submucosal lymphoid 
tissues, where they would start inflammatory reactions 
which lead to the emergence of lymphangitis, 
endarteritis, granuloma, caseous necrosis, mucosal 
ulcerations, and fibrotic tissue.3,8,11
Macroscopic feature of intestinal lesions can 
be categorized as follows: ulcerative (60%), 
hypertrophic (10%), and ulcerous-hypertrophic (30%). 
The ulcerous-hypertrophic feature is most frequently 
found in illeocaecal TB in comparison to the TB 
affecting other segments of gastrointestinal tracts. 8,11,12
CLINICAL MANIFESTATIONS
The signs and symptoms are blurry and not specific. 
The clinical manifestations might be acute, chronic, 
or acute in chronic process. As a result, the diagnosis 
of ileocaecal TB is hard to establish and requires high 
clinical suspicion rate, especially in the high-risk 
group.1,7,8,11,12,13
In literatures, it is mentioned that TB of the 
digestive system occurs more frequently in young 
adult. Two thirds of the patients are 21-40 years old 
and in several studies it was shown that the incidence 
in women is higher than that in men (2 : 1).3,4,14
In a study conducted by Khan et al the average 
age was 33 ± 15 years old with 59% of the patients 
were women. The most frequent symptoms found 
subsequently were abdominal pain, fever, night sweat, 
weight loss, nausea, vomiting, ascites, constipation, 
and diarrhea. Subacute and acute intestinal obstruction 
was found in 13% and 11% of all patients, respectively. 
The length of time the symptoms had been experienced 
before the patients received their medication for the 
first time was 265 ± 150 days. History of previous TB 
treatment was found in 6,2% of patients and a history 
of TB among family members was found in 2.9% of 
patients.7,14,15
In history of illness, the symptoms found were 
abdominal pain, night sweats, weight loss, loss of 
appetite, nausea, vomiting, and chronic diarrhea. 
Most patients have constitutional symptoms 
such as fever (40-70%), pain (80-95%), diarrhea 
(11-20%), constipation, alteration between constipation 
and diarrhea, weight loss (40-90%), anorexia and 
weakness. Unspecific chronic abdominal pain was the 
chief complaint in 80 to 90 percent of all patients. Pain 
might be colic or continuous if the mesenteric lymph 
nodes were involved.1,5,6 
Mass in lower right quadrant was palpable in 
25-50% of all patients. Intestinal obstruction and colon 
perforation were reported. Abdominal distention due 
to ascites was various between 10-65%. The presence 
of ascites could help to differentiate ileocaecal TB and 
Crohn’s disease considering that ascites is rarely found 
in Crohn’s disease. The proportion of the occurrence of 
this case along with abdominal TB is varied between 
30-40%.7,8,14,16
Table 3. Symptoms and signs of tuberculosis17
Symptoms n (%) Signs n (%)
Weight loss 49 (57) Fever 40 (46.5)
Abdominal pain 43 (50) Ascites 23 (27)
Pyrexia of 
unknown origin
36 (42) Abdominal tenderness 23 (27)
Abdominal 
distension
19 (22) Abdominal mass 10 (11.5)
Vomiting 13 (15) Peritonitis 3 (3.5)
Night sweats 7 (8) Acute bowel 
obstruction
2 (2)
Anorexia 7 (8) Jaundice 1 (1)
Cough 3 (3.5) Fistula-in-ano 1 (1)
Dysphagia 2 (2) Perianal mass 1 (1)
Shortness of 
breath
1 (1) Post-cholecystectomy 1 (1)
PR bleed + mass 
at anal margin
1 (1) Neck mass 1 (1)
Fistula-in-ano 1 (1)
In laboratory examination, routine laboratory result 
can indicate mild anemia and increased erythrocyte 
sedimentary rate in 50-80% of patients. Leukocyte 
count is usually within normal range. Positive 
tuberculin test in most of the patients with intestinal 
TB has limited diagnostic value since it cannot differ 
between active disease and previous sensitization due 
to contact or vaccination. Furthermore, purified protein 
derivative (PPD) skin test might give negative result 
in immune-compromised patients.12,13,14,16
The examination of acid-fast bacilli (AFB) of 
sputum, stools, and tissue AFB as well as the result 
of tissue AFB culture often give negative results. In 
a study conducted by Wells, Northoven and Howard, 
positive result of sputum and tissue AFB test were 
achieved only in less than 50% of all cases. A Canadian 
study, AFB culture from tissue specimen collected 
through surgical procedures only gives positive results 
in 8 out of 17 patients with abdominal TB and direct 
tissue-AFB examination gives positive results in 
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5 out of 17 patients. Khan et al showed positive results 
for mycobacterium tissue culture only in 7% of patients 
with abdominal TB and the sensitivity of acid-fast 
bacilli examination was 24.3%.8,11,12,14,16
Radiology findings are not specific. Patients’ chest 
X-ray often shows no abnormalities. This condition 
is not a wonder, considering less than 50% of patients 
show pulmonary abnormalities. The image of specific 
process in roentgen photo leads to the diagnosis, but it 
was also mentioned that a normal chest X-ray does not 
exclude abnormalities. Sharma et al found coincidence 
with pulmonary TB as much as 46%.12,13,14,16 
after TB treatment. Abdominal TB can occur with or 
without pulmonary TB.1,2,3,12,13 
Presumptive diagnosis can be made if an active 
pulmonary TB is found and/or accompanied with 
clinical or radiologic findings that are consistent to 
intestinal TB. It is essential to remember that positive 
chest X-ray findings were found in less than 50% of 
patients.2,3,13,19,20 
The definite diagnosis is based on histological 
findings, Ziehl-Neelsen staining of the acid-fast 
bacilli, and culture, although the sensitivity of each 
examination was reported to be various. Colonoscopy 
with biopsy is one of the non-operative diagnostic 
approach which is useful for acknowledging ileocaecal 
TB.19,20,21 The combination of histological examination 
and culturing biopsy material can establish the 
diagnosis in more than 80% of patients.11,21,22,23 
Deep biopsy per endoscopy is best performed 
on the margin and the base of the ulcer, considering 
granuloma of TB are often located in submucosal area. 
This situation is different with the granuloma found 
in Crohn’s disease, which are usually located in the 
mucosa.19,20,22,23
PCR examination from biopsy specimens can help 
in establishing the diagnosis with higher sensitivity 
and specificity in comparison to urine culture and 
the result can be obtained in a relatively short period 
of time.19,20,23,24,25 Anti-cord factor antibodies with 
ELISA is also regarded as being useful in establishing 
intestinal TB fast and in helping to differ it from 
Crohn’s disease.23,24 
In gastrointestinal TB, endoscopy finding is not 
pathognomonic. Finding granuloma and positive acid-
fast bacilli from the biopsy of tissue obtained through 
endoscopy are also rare occasions. TB can happen in 
all segments of the gastrointestinal tract. The region 
most commonly affected is the ileocaecal region and 
the caecum.18,22,23,26
Through colonoscopy, features can be found 
including hyperemic mucosa with erosion and 
edema, some with bleeding, visible multiple polypoid 
mass in ileocaecal valve and terminal ileus (giving 
the differentials of TB, Crohn’s, and malignancy) 
with multiple ulcerations in the rectum, ascending 
colon, and caecum. Segmental or isolated colonic TB 
comprises of 9.2% of all abdominal TB cases, and it 
usually affects sigmoid colon, ascending colon, and 
transversal colon. Multifocal involvement was seen 
in 28-44% of patients with colitis TB.22,23,26
Lee et al in a prospective analysis of endoscopic 
findings, created a scoring system in measuring 
the probability of Crohn’s disease as well as intestinal 
TB with positive prediction values of 94.9% and 
88.9%, respectively.27 Endoscopic findings supporting 
Crohn’s disease include anorectal lesion, longitudinal 
Table 4. Diagnostic yield of various investigations in patients with 
abdominal tuberculosis17
Investigations
n (patients 
in which 
investigations 
performed)
Yield of 
diagnostic test  
n/% 
Barium meal and follow 
trough
70 58/83
Barium enema 34 15/44
Ultra sound 93 82/88
CT scan abdomen 35 28/80
Histopathology of 35 35/100
Histopathology of surgical 
specimen
35 29/83
Histopathology of 
colonoscopic biopsy
28 14/50
Histopathology of ultrasound 
and CT guided biopsy
5 5/100
Histopathology of upper GI 
endoscopic biopsy
10 4/40
Acid fast bacilli culture 87 6/7
Barium enema and follow-through can show 
mucosal ulceration and stricture, caecal deformity 
and gaping, or incompetent ileocaecal valve. CT is an 
imaging modality which helps in judging intraluminal 
and extraluminal pathology as well as the distribution 
of the disease.12,14,16,15,18
Eventhough colonoscopy nowadays has largely 
replaced the role of past radiologic examination, 
double-contrast barium enema examination can 
provide a more detailed information on mucosal 
pattern and early images of intestinal TB. With a better 
understanding of early radiologic features of colitis 
TB, an earlier diagnosis using double-contrast barium 
enema is made possible.14,15,18
DIAGNOSIS 
The main problem in abdominal TB is diagnostic 
and management issues. The symptoms and signs of 
abdominal TB are usually not specific and resembles 
to other diseases.1,2,3 
Abdominal TB is established based on history of 
the disease, physical examination, lab examination and 
other diagnostic examination as well as good response 
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ulcer, aphtose ulcer, and cobblestone appearance, 
whereas endoscopic findings supporting intestinal 
tuberculosis include transversal ulcer, polypoid mass, 
the involvement of less than four segments, and 
ileocaecal-valve lesion.18,26 
Histological features of the result of colon 
biopsy often show active chronic colitis with cryptic 
destruction giving the differentials of inflammatory 
bowel diseases (IBD) and chronic bacterial/parasitic 
infection. Pulimoid et al in a study on the result of 
colonoscopic biopsy, concluded that the histologic 
features of mucosal biopsy might aid in separating 
cases of intestinal TB and Crohn’s disease, but multiple 
biopsy from different segments are required.28 It was 
also said that the accuracy of diagnosis is directly 
proportional to the amount of biopsy performed from 
rectum to the ileus.21,22,24
DIFFERENTIAL DIAGNOSIS
The differential diagnosis of ileocaecal TB includes 
actinomycosis, amebiasis, Yersinia enterocolitis, 
Crohn’s disease, lymphoma, dan adenocarcinoma. 
Biopsy helps in identifying lymphoma or carcinoma 
cell. Amebiasis is usually acute in nature even though 
some patients may experience chronic colitis or colon 
ameboma. Biopsy obtained from the ulcers found in 
mostly normal mucosa may contain the trophozoic 
phase of Entamoeba histolytica. The microorganism is 
usually found in patient’s stools and amoeba serology 
shall give positive result.21,24,29
that if a strong clinical suspicion is found in an endemic 
area, empirical therapy using anti-tuberculosis is 
allowed. Another study conducted by Ramanathan 
et al concluded that justifying the initiation of anti-
tuberculosis drugs therapy in an endemic area based 
on clinical suspicion and adequate response should 
be acceptable as a diagnostic basis of abdominal 
TB although histopathological or microbiology 
confirmation was not possible.12
Marshall JB, in a study on the length of TB 
treatment, mentioned that a therapy regimen of 6, 
9, or 18 to 24 months all were proven effective in 
the management of extrapulmonary TB. Systemic 
symptoms such as fever, anorexia, and weight loss 
can decline in 4 to 6 weeks, whereas gastrointestinal 
symptoms require a longer time.7 
In a study conducted in Saudi Arabia, it was 
reported that corticosteroid reduce the frequency of 
recurrent abdominal pain, intestinal obstruction, and 
surgical procedure as well as mortality rate. It was then 
suggested also to give corticosteroid especially in the 
case of peritonitis TB.8,9,28 
CONCLUSION
Clinical manifestations of abdominal TB are not 
specific. In a way, detailed diagnostic approaches 
and supporting results are needed to determine 
the final diagnosis. On the other side, there is 
no single examination, be it clinical symptoms, 
laboratory, radiology, endoscopy, microbiology 
or histopathological examinations are adequate to 
diagnose abdominal TB. Diagnostic approach to 
abdominal TB remains a challenge for clinicians; 
aside from the need of strong clinical judgment. 
If the diagnosis can be quickly established, this 
disease would then be able to be treated with 
conventional anti-tuberculosis drugs. Therapy for 6, 
9 and 18 to 24 months are all proven to be effective in 
the management of extrapulmonary TB.
In countries with high prevalence of abdominal 
TB, initiating a trial of anti-tuberculosis treatment 
is allowed if it is accompanied by consistent clinical 
features. Diagnosis can be established when the patient 
responds to anti-TB treatment. 
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